medroxyprogesterone acetate has been researched along with Anemia, Cooley's in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bavaro, P; Bellati, U; Bizzarri, M; Carabella, G; Iammarrone, E; Mattaeis, RD; Torlontano, G | 1 |
Buemi, M; Frisina, N; Gaudio, A; Lasco, A; Morabito, N; Wasniewska, M | 1 |
Crisafulli, A; Denuzzo, G; Frisina, N; Gaudio, A; Lasco, A; Meo, A; Morabito, N | 1 |
3 other study(ies) available for medroxyprogesterone acetate and Anemia, Cooley's
Article | Year |
---|---|
[Efficacy of estrogen-progestin replacement therapy after bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Medroxyprogesterone Acetate; Multiple Myeloma; Neural Tube Defects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Primary Ovarian Insufficiency; Progesterone Congeners; Prospective Studies | 1996 |
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major.
Topics: Adolescent; Adult; beta-Thalassemia; Bone Density; Bone Diseases, Metabolic; Case-Control Studies; Cross-Sectional Studies; Emergencies; Estradiol; Female; Guideline Adherence; Hormone Replacement Therapy; Hospitalization; Humans; Male; Medroxyprogesterone Acetate; Normal Distribution; Practice Guidelines as Topic; Regression Analysis; Statistics, Nonparametric; Testosterone | 2001 |
Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis.
Topics: Adult; beta-Thalassemia; Biomarkers; Bone and Bones; Bone Density; Cross-Sectional Studies; Deferoxamine; Estrogen Replacement Therapy; Female; Femur Neck; Hormone Replacement Therapy; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Iron Chelating Agents; Lumbar Vertebrae; Male; Medroxyprogesterone Acetate; Methyltestosterone; Osteoporosis; Reference Values | 2002 |